XML 143 R115.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue:    
Collaboration and license revenue $ 38,275 $ 26,004
Grant revenue 638 0
Total revenue 38,913 26,004
Operating expenses:    
General and administrative 30,126 40,450
Net loss (77,424) (219,710)
Reporting Segments    
Revenue:    
Collaboration and license revenue 38,275 26,004
Grant revenue 638 0
Total revenue 38,913 26,004
Operating expenses:    
Research and development employee expenses 11,952 18,363
Research and development stock-based compensation expense 3,217 12,985
Research and development facilities and other expenses 10,616 7,148
General and administrative 30,126 40,450
Impairment of long-lived assets 7,579 710
Other expense, net 33,527 133,294
Net loss (77,424) (219,710)
Reporting Segments | Legacy Selecta programs    
Operating expenses:    
Medical expenses, operating 6,150 31,826
Reporting Segments | Descartes-08 for MG    
Operating expenses:    
Medical expenses, operating 12,142 343
Reporting Segments | Early stage programs    
Operating expenses:    
Medical expenses, operating $ 1,028 $ 595